Cargando…
Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial
INTRODUCTION: The optimal duration of antibiotic therapy for community-acquired pneumonia (CAP) is unsettled. Short-course therapy has proved successful in clinical trials but is not yet implemented in everyday clinical practice. Validation of results from randomised controlled trials is crucial to...
Autores principales: | Israelsen, Simone Bastrup, Tingsgård, Sandra, Thorlacius-Ussing, Louise, Knudsen, Andreas, Lindegaard, Birgitte, Johansen, Isik S, Mygind, Lone Hagens, Ravn, Pernille, Benfield, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364160/ https://www.ncbi.nlm.nih.gov/pubmed/37479519 http://dx.doi.org/10.1136/bmjopen-2022-069013 |
Ejemplares similares
-
Short course antibiotic treatment of Gram-negative bacteraemia (GNB5): a study protocol for a randomised controlled trial
por: Tingsgård, Sandra, et al.
Publicado: (2023) -
241. Early switch from intravenous to oral antibiotics in patients with Gram-negative bacteremia – a target trial emulation
por: Tingsgård, Sandra, et al.
Publicado: (2023) -
581. Impact of Urinary Antigen Tests on Clinical Outcomes in Patients Hospitalized with Community-acquired Pneumonia
por: Kern, Marita, et al.
Publicado: (2023) -
Legionella community-acquired pneumonia (CAP) presenting with spontaneous bilateral pneumothoraces
por: Cunha, Burke A., et al.
Publicado: (2008) -
Circulating Adiponectin Levels Are Inversely Associated with Mortality and Respiratory Failure in Patients Hospitalized with COVID-19
por: Hindsberger, Bettina, et al.
Publicado: (2023)